+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis



Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis



Journal of Clinical Microbiology 35(12): 3098-3103



This study provides the first systematic evaluation of papillomavirus type and viral mutation occurring during the course of juvenile-onset recurrent respiratory papillomatosis. One hundred ninety-nine consecutive papillomas excised from 47 children between 1981 and 1996 at The New Children's Hospital in Sydney, Australia, were tested for human papillomavirus (HPV) DNA by PCR. PCR products from the viral upstream regulatory region (URR) enhancer were sequenced, and variation was related to clinical variables. Forty-four of the 47 children had HPV-induced papillomas, with type 11 accounting for 24 (55%) and type 6 accounting for 19 (43%); one (2%) was positive for either type 6 or 11. Overall, 183 (98%) of the 186 samples with amplifiable DNA were HPV positive. There was no change in HPV type over time and no statistically significant association between HPV type and disease aggressiveness. One novel, large-scale URR duplication was identified in an HPV type 11 isolate in the last of a series of six papillomas examined and the first from the bronchus. However, the duplication was not found in HPV type 11 isolates from the associated pulmonary carcinoma and its metastases in other organs. Three of 14 URR point mutations coincided with transcription factor binding sites, but there were no obvious associations with clinical course. Chi-square and multiple linear regression analyses of clinicopathological variables revealed early age at diagnosis (less than 4 years) as an independent predictor of aggressive disease (P < 0.001). A bimodal distribution of the age at diagnosis was noted, with peaks at 2 and 11 years of age.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009871495

Download citation: RISBibTeXText

PMID: 9399501


Related references

Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatric Infectious Disease Journal 27(2): 149-154, 2008

Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology 188(1): 384-387, 1992

Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue. Journal of Infectious Diseases 217(2): 177-178, 2018

Nucleotide and phylogenetic analysis of human papillomavirus type 11 isolated from juvenile-onset recurrent respiratory papillomatosis in China. Journal of Medical Virology 88(4): 686-694, 2016

Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature. Journal of the Pediatric Infectious Diseases Society 6(4): 380-385, 2017

Predictors of remission in juvenile-onset recurrent respiratory papillomatosis. Archives of Otolaryngology--Head and Neck Surgery 129(12): 1275-1278, 2003

Clinical study of juvenile-onset recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Ke Za Zhi 36(6): 458-462, 2001

Clinical study of tracheotomies children with juvenile onset recurrent respiratory papillomatosis. Lin Chuang Er Bi Yan Hou Ke Za Zhi 20(15): 704-706, 2006

HPV type determination and clinical characteristics in juvenile onset recurrent respiratory papillomatosis. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 30(9): 730-732;736, 2016

Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head and Neck 37(11): 1625-1632, 2015

Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis. European Archives of Oto-Rhino-Laryngology 257(5): 263-269, 2000

HLA-DRB1 and HLA-DQB1 alleles in Chinese Han patients with Juvenile-Onset recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 102: 119-122, 2017

HLA-DQ alleles in white and African American patients with juvenile-onset recurrent respiratory papillomatosis. Archives of Otolaryngology--Head & Neck Surgery 129(11): 1221-1224, 2003

Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. International Journal of Pediatric Otorhinolaryngology 70(3): 469-473, 2006

Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis. Laryngoscope 121(4): 846-851, 2011